Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG booster effect on TDaP-IPV vaccination in healthy adults
NL-OMON40745Recruiting
- Sponsor
- Radboudumc
- Start
- Jan 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of bcg vaccine and Boostrix Polio in pertussis, Tetanus, diphtheria and 2 more (3 arms), sponsored by Radboudumc. Primary endpoints: Pertussis-specific humoral and cellular immune responses, Gene transcription responses and 1 more. Started Jan 2015; status: recruiting.
02
Drugs
bcg vaccineBoostrix Polio
03
Conditions
pertussisTetanusdiphtheriapoliomyelitisTuberculosis (TB)
Beyond the preview
Go deeper on NL-OMON40745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40745.